EMT activates ER-to-Golgi trafficking through upregulation of REEP2 to promote lung cancer progression
A CRISPR interference in vivo screen for membrane trafficking regulators identifies REEP2 as a critical mediator of the EMT-driven pro-metastatic membrane trafficking program, revealing a specific vulnerability in mesenchymal LUAD.